|
SNX13 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.041440E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.478100E-03 |
| Normal-vs-Stage2 |
9.926000E-01 |
| Normal-vs-Stage3 |
2.39560000003802E-06 |
| Normal-vs-Stage4 |
5.76409999730743E-08 |
| Stage1-vs-Stage2 |
3.139200E-01 |
| Stage1-vs-Stage3 |
3.817600E-03 |
| Stage1-vs-Stage4 |
3.228900E-04 |
| Stage2-vs-Stage3 |
3.662200E-02 |
| Stage2-vs-Stage4 |
2.162200E-02 |
| Stage3-vs-Stage4 |
6.919400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.989700E-04 |
| Normal-vs-AfricanAmerican |
1.173930E-04 |
| Normal-vs-Asian |
7.564400E-02 |
| Caucasian-vs-AfricanAmerican |
1.587850E-01 |
| Caucasian-vs-Asian |
7.998800E-01 |
| AfricanAmerican-vs-Asian |
8.189800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.627300E-04 |
| Normal-vs-Female |
6.38219999999912E-05 |
| Male-vs-Female |
4.232400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.374550E-04 |
| Normal-vs-Age(41-60Yrs) |
1.074060E-02 |
| Normal-vs-Age(61-80Yrs) |
1.398570E-04 |
| Normal-vs-Age(81-100Yrs) |
1.552060E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.341600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.533840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.716400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.161400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.841700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.144010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.276200E-01 |
| Normal-vs-Grade 2 |
1.584970E-01 |
| Normal-vs-Grade 3 |
3.49829999968243E-07 |
| Normal-vs-Grade 4 |
2.7485791420645E-12 |
| Grade 1-vs-Grade 2 |
9.147000E-01 |
| Grade 1-vs-Grade 3 |
1.335420E-01 |
| Grade 1-vs-Grade 4 |
1.216090E-03 |
| Grade 2-vs-Grade 3 |
2.477600E-03 |
| Grade 2-vs-Grade 4 |
2.20970000075482E-08 |
| Grade 3-vs-Grade 4 |
2.007200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.025380E-01 |
| Normal-vs-ccB subtype |
1.064320E-02 |
| ccA subtype-vs-ccB subtype |
1.906200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.439100E-03 |
| Normal-vs-N1 |
8.14540000000363E-05 |
| N0-vs-N1 |
9.887600E-02 |
|
|
